FAQs
TFF Pharmaceuticals’ corporate headquarters are located in Fort Worth, TX.
TFF Pharmaceuticals is incorporated in the state of Delaware.
TFF Pharmaceuticals operates on a fiscal year with a year-end of December 31.
TFF Pharmaceuticals is traded on the NASDAQ stock exchange under the symbol “TFFP”.
TFF Pharmaceuticals’ transfer agent is Pacific Stock Transfer. For more information, visit their website: https://pacificstocktransfer.com/
You must send both your old and new addresses to our transfer agent, Pacific Stock Transfer. Contact info@pacificatocktransfer.com. Each stakeholder in question must sign the request for an address change.
Please contact Pacific Stock Transfer at info@pacificatocktransfer.com. The company can look up your records and make any needed adjustments. Generally, there is a fee involved for replacing lost certificates.
TFF Pharmaceuticals does not offer a direct stock purchase plan.
Marcum LLP
Greenberg Traurig LLP
You can view our latest press releases by visiting “News” under the “Investors” section of our website. If you would like to receive email alerts regarding our press releases, please visit our email alerts page.
TFF Pharmaceuticals’ SEC filings can be accessed under “Financial Information” in the “Investors” section of our corporate website or https://www.sec.gov
All investor inquiries should be emailed to Jason Nelson at Core IR investorinfo@tffpharma.com.